These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Hacohen H; Gurtner B Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377 [No Abstract] [Full Text] [Related]
5. Amantadine in the treatment of Parkinson's disease. Schwab RS; England AC; Poskanzer DC; Young RR JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715 [No Abstract] [Full Text] [Related]
6. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. Sigwald J; Raymondeaud C Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538 [No Abstract] [Full Text] [Related]
7. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
8. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J; Raymondeaud C; Piot C Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
9. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
10. [Amantadine hydrochloride in the treatment of Parkinson's syndrome]. De la HerrĂ¡n J; Figuerido JA Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472 [No Abstract] [Full Text] [Related]
11. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Schneider E; Fischer PA; Jacobi P Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456 [No Abstract] [Full Text] [Related]
12. [Problematic long-term therapy of Parkinson's syndrome using amantadine salts]. Diehl LW Med Welt; 1975 Nov; 26(48):2188-91. PubMed ID: 813085 [No Abstract] [Full Text] [Related]
13. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
14. Amantadine and levodopa in the treatment of Parkinson's disease. Walker JE; Potvin A; Tourtellotte W; Albers J; Repa B; Henderson W; Snyder D Clin Pharmacol Ther; 1972; 13(1):28-36. PubMed ID: 4550321 [No Abstract] [Full Text] [Related]
15. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
16. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome. Fehling C Acta Neurol Scand; 1973; 49(2):245-51. PubMed ID: 4577929 [No Abstract] [Full Text] [Related]
17. L-dopa and amantadine for Parkinsonism. Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244 [No Abstract] [Full Text] [Related]
18. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Fieschi C; Casacchia M; Nardini M; Reitano N Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075 [No Abstract] [Full Text] [Related]
19. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
20. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease]. Gomirato G; Perfetti C Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838 [No Abstract] [Full Text] [Related] [Next] [New Search]